Track EZZ Life Science Holdings Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

EZZ Life Science Holdings Limited EZZ.AX · Stock Open EZZ Life Science Holdings Limited in new tab

0.4250 AUD
P/E
8.50
EPS
0.06
Yield
8.99%
Safety Score
42
P/B
0.86
ROE
11.15
Beta
0.88
Loading chart...
Key Metrics
Earnings dateSept. 2, 2026
P/E8.50
EPS0.06
Book Value0.59
Price to Book0.86
Debt/Equity0.45
% Insiders74.161%
Growth
Revenue Growth-0.18%
Earnings Growth-0.44%
Estimates
Forward P/E2.12
Forward EPS0.24
Dividend
Dividend Yield8.99%
Annual dividends0.04 AUD
Ex-Div. DateNov. 24, 2025
Payout63.89%

DCF Valuation

Tweak assumptions to recompute fair value for EZZ Life Science Holdings Limited (EZZ.AX)
Currency: AUD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

EZZ Life Science Holdings Limited Logo EZZ Life Science Holdings Limited Analysis (EZZ.AX)

Australia Consumer Staples Official Website Stock

Is EZZ Life Science Holdings Limited a good investment? EZZ Life Science Holdings Limited (EZZ.AX) is currently trading at 0.4250 AUD.

In terms of valuation, the stock trades at a P/E ratio of 8.50. This relatively low multiple may signal that EZZ Life Science Holdings Limited is undervalued compared to historical market norms.

Earnings Schedule: EZZ Life Science Holdings Limited is expected to release its next earnings report on Sept. 2, 2026. The market consensus estimate for Forward EPS is 0.24.

For income investors, EZZ Life Science Holdings Limited pays a dividend yield of 8.99%. With a payout ratio of 64%, the dividend appears sustainable.

Investor FAQ

Does EZZ Life Science Holdings Limited pay a dividend?

Yes, it pays an annual dividend of 0.04 AUD (8.99% yield).

What asset class is EZZ Life Science Holdings Limited?

EZZ Life Science Holdings Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Sept. 2, 2026. The company currently has a trailing EPS of 0.06.

Company Profile

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. The company was incorporated in 2015 and is based in Lidcombe, Australia.

Exchange Ticker
ASX (Australia) EZZ.AX
Trades
Dividend Yield
8.99%
Annual Dividends
0.04AUD
Next Ex. Div Date
Nov. 24, 2025
Payout Ratio
63.89%
Dividend History paid per year (AUD)
Historical Dividends
Year Total Dividends
2026
0.09 AUD
Dec. 16, 2026 (estimated) 0.0348
Nov. 5, 2026 (estimated) 0.0200
June 17, 2026 (estimated) 0.0306
2025
0.06 AUD
Dec. 23, 2025 0.0200
Nov. 24, 2025 0.0200
June 17, 2025 0.0200
2024
0.06 AUD
Dec. 9, 2024 0.0200
Nov. 5, 2024 0.0200
June 17, 2024 0.0150
2023
0.02 AUD
Dec. 8, 2023 0.0100
June 23, 2023 0.0098
2022
0.00 AUD
Dec. 16, 2022 0.0045
2021
0.00 AUD
Dec. 16, 2021 0.0045
Upcoming Dividends
Name Payment Date Status Amount
EZZ Life Science Holdings Limited Nov 24, 2025 0.02 AUD
EZZ Life Science Holdings Limited Dec 23, 2025 0.02 AUD
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion